Skip to main content

Table 1 Patient demographics before and after propensity score matching

From: Comparison of survival in elderly patients treated with uretero-cutaneostomy or ileal conduit after radical cystectomy

 

Ileal Conduit

Uretero-cutaneostomy

p

Before Matching

n

1093

301

 

Age (median [IQR])

82.00 [81.00, 85.00]

83.00 [81.00, 85.00]

0.596

Sex (n (%))

  

< 0.001

 Female

177 (16.2)

11 (3.7)

 

 Male

916 (83.8)

290 (96.3)

 

Marital Status (n (%))

  

0.132

 Married

695 (63.6)

187 (62.1)

 

 Single

361 (33.0)

96 (31.9)

 

 Unknown

37 (3.4)

18 (6.0)

 

Year of Diagnosis (n(%))

  

< 0.001

 2004 ~ 2010

658 (60.2)

231 (76.7)

 

 2011 ~ 2016

435 (39.8)

70 (23.3)

 

Race/Ethnicity (n(%))

  

0.940

 White

995 (91.0)

273 (90.7)

 

 Black

48 (4.4)

13 (4.3)

 

 Asian

50 (4.6)

15 (5.0)

 

Insurance (n(%))

  

< 0.001

 Insured

831 (76.0)

192 (63.8)

 

 Uninsured

6 (0.5)

1 (0.3)

 

 Unknown

256 (23.4)

108 (35.9)

 

Tumor Grade (n (%))

  

0.261

 Urothelial Carcinoma, Low Grade

33 (3.0)

16 (5.3)

 

 Urothelial Carcinoma, High Grade

946 (86.6)

252 (83.7)

 

 Urothelial Carcinoma, NOS

15 (1.4)

5 (1.7)

 

 non-Urothelial Carcinoma

99 (9.1)

28 (9.3)

 

Tumor Stage (n (%))

  

0.159

 Localized

398 (36.4)

123 (40.9)

 

 Regional

620 (56.7)

151 (50.2)

 

 Distant

72 (6.6)

26 (8.6)

 

 Unknown

3 (0.3)

1 (0.3)

 

Tumor Size (n (%))

  

0.169

 Less than 3 cm

262 (24.0)

68 (22.6)

 

 Greater than 3 cm

508 (46.5)

127 (42.2)

 

 Unknown

323 (29.6)

106 (35.2)

 

Node Density (n(%))

  

0.021

 None

611 (55.9)

160 (53.2)

 

  ≤ 0.2

133 (12.2)

22 (7.3)

 

 >0.2

117 (10.7)

38 (12.6)

 

 Unknown

232 (21.2)

81 (26.9)

 

After Matching

n

285

285

 

Age (median [IQR])

82.00 [81.00, 84.00]

83.00 [81.00, 85.00]

0.689

Sex (n (%))

  

0.835

 Female

13 (4.6)

11 (3.9)

 

 Male

272 (95.4)

274 (96.1)

 

Marital Status (n (%))

  

0.818

 Married

183 (64.2)

180 (63.2)

 

 Single

93 (32.6)

93 (32.6)

 

 Unknown

9 (3.2)

12 (4.2)

 

Year of Diagnosis (n(%))

  

0.128

 2004 ~ 2010

231 (81.1)

215 (75.4)

 

 2011 ~ 2016

54 (18.9)

70 (24.6)

 

Race/Ethnicity (n(%))

  

0.655

 White

258 (90.5)

262 (91.9)

 

 Black

11 (3.9)

12 (4.2)

 

 Asian

16 (5.6)

11 (3.9)

 

Insurance (n(%))

  

0.895

 Insured

186 (65.3)

190 (66.7)

 

 Uninsured

1 (0.4)

1 (0.4)

 

 Unknown

98 (34.4)

94 (33.0)

 

Tumor Grade (n (%))

  

0.967

 Urothelial Carcinoma, Low Grade

15 (5.3)

13 (4.6)

 

 Urothelial Carcinoma, High Grade

241 (84.6)

240 (84.2)

 

 Urothelial Carcinoma, NOS

5 (1.8)

5 (1.8)

 

 non-Urothelial Carcinoma

24 (8.4)

27 (9.5)

 

Tumor Stage (n (%))

  

0.851

 Localized

106 (37.2)

116 (40.7)

 

 Regional

154 (54.0)

146 (51.2)

 

 Distant

24 (8.4)

22 (7.7)

 

 Unknown

1 (0.4)

1 (0.4)

 

Tumor Size (n (%))

  

0.581

 Less than 3 cm

74 (26.0)

67 (23.5)

 

 Greater than 3 cm

127 (44.6)

123 (43.2)

 

 Unknown

84 (29.5)

95 (33.3)

 

Node Density (n(%))

  

0.408

 None

166 (58.2)

155 (54.4)

 

  ≤ 0.2

24 (8.4)

22 (7.7)

 

 >0.2

38 (13.3)

34 (11.9)

 

 Unknown

57 (20.0)

74 (26.0)

 
  1. NOS Not Otherwise Specified, IQR Interquartile Range. Node density is nodes positive divided by nodes examined after surgery